PWA
DTIL icon

Physician Wealth Advisors’s Precision BioSciences DTIL Stock Holding History

Physician Wealth Advisors’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-196
Closed -$1.08K – 2067
2025
Q3 		$1.08K Buy
+196
New +$939 ﹤0.01% 1528

Other funds holding DTIL

EAM
Empery Asset Management New York $83M AUM
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Physician Wealth Advisors's DTIL Position: Q4 2025 in Review

Physician Wealth Advisors sold out of Precision BioSciences (DTIL) in Q4 2025, closing a stake of 196 shares — an estimated $1.08K sold.

Physician Wealth Advisors first reported a position in DTIL in Q3 2025 and held it in 1 quarter. The position peaked at $1.08K in Q3 2025. 69 funds tracked by Wall St. Rank hold DTIL as of Q4 2025.

  • Physician Wealth Advisors reported no remaining Precision BioSciences position as of Q4 2025 after selling out during the quarter.
  • Physician Wealth Advisors sold 196 Precision BioSciences shares in Q4 2025, an estimated $1.08K.
  • Physician Wealth Advisors first reported a position in Precision BioSciences in Q3 2025 and held it in 1 quarter.
  • Physician Wealth Advisors's Precision BioSciences position peaked at $1.08K in Q3 2025.
  • 69 funds tracked by Wall St. Rank held Precision BioSciences as of Q4 2025.

Based on Physician Wealth Advisors's 13F filing for Q4 2025, filed 29 Jan 2026.